Linda M. Liau

CIK: 0001890712

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CLPT

ClearPoint Neuro, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

CLPT
ClearPoint Neuro, Inc.
May 21, 2026
Award(A)
Restricted Stock Units
Direct
12.8K shares-
CLPT
ClearPoint Neuro, Inc.
May 19, 2026
Exercise(M)
Direct
12.4K shares-
CLPT
ClearPoint Neuro, Inc.
May 22, 2025
Award(A)
Restricted Stock Units
Direct
12.4K shares-
CLPT
ClearPoint Neuro, Inc.
May 16, 2025
Exercise(M)
Direct
21.1K shares-
CLPT
ClearPoint Neuro, Inc.
Jan 2, 2025
Award(A)
Direct
193 shares at avg. $15.38$3K
CLPT
ClearPoint Neuro, Inc.
Oct 1, 2024
Award(A)
Direct
264 shares at avg. $11.21$3K

		Type	Shares	Price		Ownership
May 21, 2026	CLPT ClearPoint Neuro, Inc.	Award(A) Restricted Stock Units	12,820	-	-	Direct
May 19, 2026	CLPT ClearPoint Neuro, Inc.	Exercise(M)	12,417	-	$0	Direct
May 22, 2025	CLPT ClearPoint Neuro, Inc.	Award(A) Restricted Stock Units	12,417	-	-	Direct
May 16, 2025	CLPT ClearPoint Neuro, Inc.	Exercise(M)	21,093	-	-	Direct
Jan 2, 2025	CLPT ClearPoint Neuro, Inc.	Award(A)	193	$15.38	$2,968	Direct
Oct 1, 2024	CLPT ClearPoint Neuro, Inc.	Award(A)	264	$11.21	$2,959	Direct

1-6 of 6 transactions

About LIAU LINDA M.

LIAU LINDA M. (SEC CIK 0001890712) files insider reports with the SEC as Director of ClearPoint Neuro, Inc. (CLPT).

Signal8 holds 6 ownership filings by LIAU LINDA M., all Form 4s, filed between Oct 2, 2024 and May 26, 2026. Those filings report 6 transactions, from Oct 1, 2024 to May 21, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on LIAU LINDA M.'s filings is in SOLANA BEACH, CA.

Recent filings by LIAU LINDA M.

May 21, 2026: Grant or award of CLPT derivative securities (Form 4, code A).
May 19, 2026: Option exercise of CLPT shares (Form 4, code M).
May 22, 2025: Grant or award of CLPT derivative securities (Form 4, code A).
May 16, 2025: Option exercise of CLPT shares (Form 4, code M).
Jan 2, 2025: Grant or award of CLPT shares (Form 4, code A).

Other insiders filing for ClearPoint Neuro, Inc. (CLPT)

Richards Timothy T., Director
FLETCHER R JOHN, Director
BURNETT JOSEPH, CEO and President
STIGALL L. JEREMY, Chief Business Officer
D'Alessandro Danilo, Chief Financial Officer
FALLON LYNNETTE C, Director

How to read Form 4 transaction codes